Date: Jan 20, 2014 Author: Chris Walker Source: MassDevice (
click here to go to the source)
Cardialen is closing in on a $4 million equity round, after raising $2.5 million from 18 unnamed investors.
Minneapolis and St. Louis-based Cardialen is developing a low-energy implant for atrial fibrillation designed to control the fibrillation without damaging heart tissue, according to its website.
The technology uses series of lower-energy pulses rather than a single high-energy shock to effect the therapy, according to the website.
Sign up to get our free newsletters delivered straight to your inbox
The company has offered its 18 investors equity in Cardialen for the $2.5 million, according to the filing.
